{"DataElement":{"publicId":"7801637","version":"1","preferredName":"Patient Primary Neoplasm Adjuvant Radiation Therapy Clinical Trial Eligibility Criteria Code Indicator","preferredDefinition":"The coded response as to whether the patient meets the eligibility criteria for clinical trial participation with regards to adjuvant radiation therapy to the primary neoplasm.","longName":"RADPRIMWLE","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"7801636","version":"1","preferredName":"Patient Primary Neoplasm Adjuvant Radiation Therapy Clinical Trial Eligibility Criteria","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._A tumor at the original site of origin._An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself._Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2233604v1.0:7801634v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7801634","version":"1","preferredName":"Primary Neoplasm Adjuvant Radiation Therapy Clinical Trial Eligibility Criteria","preferredDefinition":"A tumor at the original site of origin.:An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.:Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C8509:C2140:C15313:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Adjuvant","conceptCode":"C2140","definition":"An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCD4D5F-6583-38D4-E053-4EBD850AC397","latestVersionIndicator":"Yes","beginDate":"2021-11-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-11-02","modifiedBy":"ONEDATA","dateModified":"2021-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCD4D5F-6594-38D4-E053-4EBD850AC397","latestVersionIndicator":"Yes","beginDate":"2021-11-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-11-02","modifiedBy":"TAYLORT","dateModified":"2021-12-09","changeDescription":"12/9/21 TL released AI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7801087","version":"1","preferredName":"Code Indicator","preferredDefinition":"A symbol or combination of symbols which is assigned to the members of a collection._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"7801087v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"2","valueDescription":"N/A","ValueMeaning":{"publicId":"2561784","version":"1","preferredName":"N/A","longName":"2561784","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BE65-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-09","modifiedBy":"KUMMEROA","dateModified":"2023-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF5C43B4-9CCB-4AC7-E053-4EBD850A927C","beginDate":"2021-10-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"0","valueDescription":"No","ValueMeaning":{"publicId":"3216924","version":"1","preferredName":"No","longName":"3216924v1.00","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FB8B94D-C670-2CB0-E040-BB89AD4377A2","latestVersionIndicator":"Yes","beginDate":"2011-03-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2011-03-30","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF5C43B4-9CDF-4AC7-E053-4EBD850A927C","beginDate":"2021-10-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"},{"value":"1","valueDescription":"Yes","ValueMeaning":{"publicId":"6594241","version":"1","preferredName":"Yes","longName":"6594241v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D3DC576-80CA-66DB-E053-F662850AEDCD","latestVersionIndicator":"Yes","beginDate":"2018-12-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-12-17","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CF5C43B4-9CE9-4AC7-E053-4EBD850A927C","beginDate":"2021-10-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-27","modifiedBy":"ONEDATA","dateModified":"2021-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208003","version":"1","preferredName":"Code Indicator","preferredDefinition":"A system of numbered categories for representation of data.:An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25162:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3874-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF5C43B4-9CA9-4AC7-E053-4EBD850A927C","latestVersionIndicator":"Yes","beginDate":"2021-10-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-10-27","modifiedBy":"TAYLORT","dateModified":"2021-12-09","changeDescription":"12/9/21 TL released AI. 10/27/21 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Planned adjuvant radiotherapy","type":"Preferred Question Text","description":"Planned adjuvant radiotherapy to the primary melanoma site after Wide Local Excision is not permitted as part of the protocol and any patients given this treatment would be excluded from the study.","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFCD0B43-19E0-38D7-E053-4EBD850A793A","latestVersionIndicator":"Yes","beginDate":"2021-11-02","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-11-02","modifiedBy":"TAYLORT","dateModified":"2021-12-09","changeDescription":"12/9/21 TL released AI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}